Diabetes and Hair Loss: Unraveling the Interconnected Pathways

Diabetes, a complex metabolic disorder, has far-reaching effects on various body systems, including the skin and hair. Emerging research suggests a bidirectional relationship between diabetes and hair health, where diabetes can contribute to hair loss, and changes in hair characteristics might signal underlying diabetic conditions. This article reviews the potential mechanisms by which diabetes might promote hair loss and reflect the diabetic status of an individual, integrating insights from various studies in the field.

Introduction: Diabetes mellitus, particularly Type 2 Diabetes (DM2), is a global health concern characterized by hyperglycemia and associated metabolic disturbances. While its impact on cardiovascular health, kidney function, and neural pathways is well-documented, the relationship between diabetes and hair health is an area of growing interest. Hair loss or altered hair growth can be both a complication of diabetes and a potential early indicator of metabolic syndrome or prediabetic states.

Mechanistic Insights into the Diabetes-Hair Loss Connection: While the mechanism that underlies hair loss associated with diabetes has not been proven, there are several possible communication and signaling systems that have been suggested could be relevant:

  1. Impaired Blood Circulation: One of the primary mechanisms linking diabetes to hair loss is likely the impairment of blood circulation. Diabetes often leads to microvascular and macrovascular complications, hindering blood flow to extremities, including the scalp. Hair follicles, highly dependent on adequate blood supply for nourishment, suffer in this compromised environment, leading to weakened hair growth or hair loss.
  2. Hormonal Imbalances: Diabetes is intricately linked with hormonal imbalances, including insulin resistance and its cascading effects on other hormones. Such imbalances can disrupt the hair growth cycle, leading to conditions like androgenic alopecia (AGA). Studies have shown a correlation between early-onset AGA and metabolic syndrome, a cluster of conditions including increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels, which often accompany diabetes.
  3. Immune System Dysfunction: Diabetes, particularly when poorly managed, can weaken the immune system. This predisposition increases the susceptibility to skin infections and conditions like scalp fungal infections. Indirectly, this could negatively impact hair health and growth in people with diabetes.
  4. Stress and Psychological Impact: The chronic nature of diabetes management can induce significant stress, a known trigger for hair loss conditions such as telogen effluvium. Moreover, the psychological impact of dealing with a chronic illness can exacerbate stress-related hair loss. While this link between diabetes and hair loss is indirect, it should not be ignored.
  5. Nutritional Deficiencies: Diabetes can affect nutritional absorption and lead to deficiencies in biotin, zinc, magnesium and other essential nutrients vital for hair health. These deficiencies can manifest as weakened hair growth or diffuse hair thinning.
  6. Diabetic Medications: Some medications used for diabetes management have side effects that include hair thinning or hair loss. Thus, it is also important to consider the pharmacological aspect of diabetes management in relation to hair health.

Hair as a Marker of Diabetic Status: Intriguingly, changes in hair characteristics might also serve as early markers for diabetes or prediabetic states. For instance, studies have shown alterations in scalp hair morphology in diabetic children, including changes in hair bulb and shaft diameters. These changes were indicative of nutritional deficits, potentially linked to their diabetes.

Another dimension of this relationship is evident in studies exploring the association between metabolic syndrome (MetS) and hair loss patterns, particularly in women. Female pattern hair loss (FPHL) has been significantly associated with MetS, suggesting that hair loss in women could be an early indicator of underlying metabolic disturbances common in diabetes.

Moreover, the association of AGA with insulin resistance and cardiovascular risk factors in both men and women further underscores the potential of hair characteristics as non-invasive markers for early detection of metabolic syndrome and diabetes. Early onset AGA, in particular, has been proposed as a marker for metabolic syndrome and carotid artery atherosclerosis.

One medical journal publication suggests hair loss may not just be limited to the scalp, but hair loss might also occur on the lower legs and this could be used as a sign of diabetic status in a person. Such a phenomena could be related to the poor blood circulation in the extremities associated with diabetes.

Implications for Clinical Practice: The interplay between diabetes and hair health has significant implications for clinical practice. Recognizing hair loss as a potential early sign of metabolic disturbances or diabetes could lead to earlier intervention and management, potentially mitigating the progression of these conditions. It also underscores the importance of a holistic approach to diabetes management, considering the patient’s overall dermatological health.

Future Research: Future research should focus on elucidating the molecular pathways connecting diabetes with hair follicle health. Investigating the role of specific hormones, growth factors, and cytokines in this relationship could unveil novel therapeutic targets. Additionally, large-scale epidemiological studies are needed to firmly establish hair characteristics as reliable markers for early diabetes or metabolic syndrome.

Conclusion: The relationship between diabetes and hair loss is multifaceted, involving impaired blood circulation, hormonal imbalances, immune dysfunction, stress, nutritional deficiencies, and medication side effects. Recognizing these connections is crucial for comprehensive diabetes management and leveraging hair characteristics as potential early markers of diabetic conditions. As research progresses, a deeper understanding of these mechanisms will pave the way for more effective interventions and holistic care strategies in diabetes management.

Bibliography

1.
Klam WP, Roeder LM, Rosebrough RH, Heald FP. Scalp hair morphology in normal and diabetic children and adolescents. J Adolesc Health Care. 1983 Jun;4(2):91–3.
1.
Matilainen V, Laakso M, Hirsso P, Koskela P, Rajala U, Keinänen-Kiukaanniemi S. Hair loss, insulin resistance, and heredity in middle-aged women. A population-based study. J Cardiovasc Risk. 2003 Jun;10(3):227–31.
1.
Hirsso P, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men. Finnish population-based study. Cent Eur J Public Health. 2006 Jun;14(2):78–81.
1.
Ekmekci TR, Ucak S, Basat O, Koslu A, Altuntas Y. The presence of insulin resistance and comparison of various insulin sensivity indices in women with androgenetic alopecia. Eur J Dermatol. 2007;17(1):21–5.
1.
González-González JG, Mancillas-Adame LG, Fernández-Reyes M, Gómez-Flores M, Lavalle-González FJ, Ocampo-Candiani J, et al. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol (Oxf). 2009 Oct;71(4):494–9.
1.
Mumcuoglu C, Ekmekci TR, Ucak S. The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia. Eur J Dermatol. 2011;21(1):79–82.
1.
Yi SM, Son SW, Lee KG, Kim SH, Lee SK, Cho ER, et al. Gender-specific association of androgenetic alopecia with metabolic syndrome in a middle-aged Korean population. Br J Dermatol. 2012 Aug;167(2):306–13.
1.
Cakir E. Is prediabetes risk factor for hair loss? Med Hypotheses. 2012 Dec;79(6):879.
1.
Chakrabarty S, Hariharan R, Gowda D, Suresh H. Association of premature androgenetic alopecia and metabolic syndrome in a young Indian population. Int J Trichology. 2014 Apr;6(2):50–3.
1.
Bakry OA, Shoeib MAM, El Shafiee MK, Hassan A. Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study. Indian Dermatol Online J. 2014 Jul;5(3):276–81.
1.
Banger HS, Malhotra SK, Singh S, Mahajan M. Is Early Onset Androgenic Alopecia a Marker of Metabolic Syndrome and Carotid Artery Atherosclerosis in Young Indian Male Patients? Int J Trichology. 2015;7(4):141–7.
1.
Miranda JJ, Taype-Rondan A, Tapia JC, Gastanadui-Gonzalez MG, Roman-Carpio R. Hair follicle characteristics as early marker of Type 2 Diabetes. Med Hypotheses. 2016 Oct;95:39–44.
1.
El Sayed MH, Abdallah MA, Aly DG, Khater NH. Association of metabolic syndrome with female pattern hair loss in women: A case-control study. Int J Dermatol. 2016 Oct;55(10):1131–7.
1.
Dharam Kumar KC, Kishan Kumar YH, Neladimmanahally V. Association of Androgenetic Alopecia with Metabolic Syndrome: A Case-control Study on 100 Patients in a Tertiary Care Hospital in South India. Indian J Endocrinol Metab. 2018;22(2):196–9.
1.
Lie C, Liew CF, Oon HH. Alopecia and the metabolic syndrome. Clin Dermatol. 2018;36(1):54–61.
1.
Katrak S, Chaudhari A, Patel R, Khadilkar S. A Simple and Reliable Clinical Indicator for Rapid Evaluation of Neuropathy in Busy Diabetes Clinics: “Hair Loss Sign.” Indian J Endocrinol Metab. 2019;23(5):585–6.
1.
Swaroop MR, Kumar BM, Sathyanarayana BD, Yogesh D, Raghavendra JC, Kumari P. The Association of Metabolic Syndrome and Insulin Resistance in Early-Onset Androgenetic Alopecia in Males: A Case-Control Study. Indian J Dermatol. 2019;64(1):23–7.
1.
Elhabak DM, Abdel Halim WA. YKL-40 A Sensitive Biomarker for Early Androgenetic Alopecia and Early Hidden Metabolic Syndrome. Int J Trichology. 2020;12(2):49–55.
1.
Mustafa AI, Abel Halim WAE, Eman F, Doaa EH. Metabolic syndrome in androgenetic alopecia patients; Is serum regulated on activation, normal T-cell expressed and secreted the missing link? J Cosmet Dermatol. 2021 Jul;20(7):2270–6.
1.
Krysiak R, Kowalcze K, Okopień B. Impaired metabolic effects of metformin in men with early-onset androgenic alopecia. Pharmacol Rep. 2022 Feb;74(1):216–28.
1.
Qiu Y, Zhou X, Fu S, Luo S, Li Y. Systematic Review and Meta-analysis of the Association Between Metabolic Syndrome and Androgenetic Alopecia. Acta Derm Venereol. 2022 Feb 8;102:adv00645.
1.
Hamed AM, Fatah MA, Shams GM. Androgenetic Alopecia and Metabolic Syndrome: Is Alarin a Missing Link? J Clin Aesthet Dermatol. 2022 Jul;15(7):32–7.
1.
Wu Y, Hui Y, Liu F, Chen H, Liu K, Chen Q, et al. The Association of Serum Adipokines, Insulin Resistance and Vitamin D Status in Male Patients with Androgenetic Alopecia. Clin Cosmet Investig Dermatol. 2023;16:419–27.